Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B PATY

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Diseases of the Colon and Rectum|January 24, 2002
Abdominoperineal resection for rectal cancer at a specialty centerA Nissan, J G Guillem, P B Paty, et al.
Annals of Surgical Oncology|April 8, 2003
Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified?J E Hartley, R A Lopez, P B Paty, et al.
The British Journal of Surgery|June 15, 2012
Multivisceral resections for rectal cancerJ D Smith, G M Nash, M R Weiser, et al.
Journal of the American College of Surgeons|January 23, 1999
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable diseaseW R Jarnagin, Y Fong, A Ky, et al.
Diseases of the Colon and Rectum|July 20, 1999
All patients with small intramural rectal cancers are at risk for lymph node metastasisD Blumberg, P B Paty, J G Guillem, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancerK M Alektiar, M J Zelefsky, P B Paty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancerK Yoshimatsu, D Golijanin, P B Paty, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 20, 1999
T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyN B Merchant, J G Guillem, P B Paty, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancerL B Harrison, B D Minsky, W E Enker, et al.
Journal of the American College of Surgeons|May 16, 1998
Stage I rectal cancer: identification of high-risk patientsD Blumberg, P B Paty, A I Picon, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Diseases of the Colon and Rectum|January 24, 2002
Abdominoperineal resection for rectal cancer at a specialty centerA Nissan, J G Guillem, P B Paty, et al.
Annals of Surgical Oncology|April 8, 2003
Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified?J E Hartley, R A Lopez, P B Paty, et al.
The British Journal of Surgery|June 15, 2012
Multivisceral resections for rectal cancerJ D Smith, G M Nash, M R Weiser, et al.
Journal of the American College of Surgeons|January 23, 1999
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable diseaseW R Jarnagin, Y Fong, A Ky, et al.
Diseases of the Colon and Rectum|July 20, 1999
All patients with small intramural rectal cancers are at risk for lymph node metastasisD Blumberg, P B Paty, J G Guillem, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancerK M Alektiar, M J Zelefsky, P B Paty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancerK Yoshimatsu, D Golijanin, P B Paty, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 20, 1999
T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyN B Merchant, J G Guillem, P B Paty, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancerL B Harrison, B D Minsky, W E Enker, et al.
Journal of the American College of Surgeons|May 16, 1998
Stage I rectal cancer: identification of high-risk patientsD Blumberg, P B Paty, A I Picon, et al.
Pageof 6